Epidemiological evolution of COVID-19 in Brazil and worldwide

Detalhes bibliográficos
Autor(a) principal: Sousa, Grasyele Oliveira
Data de Publicação: 2020
Outros Autores: Sales, Bruno Nascimento, Rodrigues, Aldenora Maria Ximenes, Rocha, Gabriel Mauriz de Moura, Oliveira, Guilherme Antônio Lopes de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/4653
Resumo: Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.
id UNIFEI_5bd7b9e995df85e23cf44a43e877d9c7
oai_identifier_str oai:ojs.pkp.sfu.ca:article/4653
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Epidemiological evolution of COVID-19 in Brazil and worldwideEvolución epidemiológica de COVID-19 en Brasil y en todo el mundoEvolução epidemiológica da COVID-19 no Brasil e no mundoCoronavírusPandemiaEpidemiologiaMortalidade.CoronavirusPandemiaEpidemiologíaMortalidad.CoronavirusPandemicEpidemiologyMortality.Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.Objetivo: analizar la evolución epidemiológica de COVID-19 en Brasil en correlación con el escenario mundial actual. Metodología: este es un estudio epidemiológico analítico y documental con un enfoque cuantitativo y descriptivo de datos secundarios del COVID-19 del Boletín Epidemiológico Especial número 15 del Ministerio de Salud de Brasil sobre la situación epidemiológica hasta el 8 de mayo de 2020. Resultados: Estados Unidos lidera en número de casos confirmados 1.318.787 (33%) y muertes 78.503 (28%) en el mundo. Brasil, ocupa el octavo lugar con 145,328 (4%) de los casos confirmados de COVID-19, su letalidad es de 6.8% y la mortalidad es de 46.6 por 1,000,000 de habitantes. En 2020, se registraron 107.895 hospitalizaciones por síndrome respiratorio agudo severo en Brasil, de las cuales 27.086 (25%) fueron casos confirmados de COVID-19 y 7.514 (28%) murieron, con personas de 60 años o más 5.697 (69%) de los casos y enfermedades cardíacas y diabetes fueron los grupos de riesgo que se destacaron considerablemente en las muertes de ancianos. Conclusión: la enfermedad aún no está bajo control, la distancia social y el uso de máscaras son la mejor manera de prevenir la progresión de casos y muertes por COVID-19.Objetivo: analisar a evolução epidemiológica da COVID-19 no Brasil correlacionando ao cenário mundial atual. Metodologia: trata-se de um estudo epidemiológico analítico e documental com abordagem quantitativa e descritiva de dados secundários da COVID-19 do Boletim Epidemiológico Especial número 15 do Ministério da Saúde do Brasil sobre a situação epidemiológica até o dia 08 de maio de 2020.  Resultados: os Estados Unidos lideram em número de casos confirmados 1.318.787 (33%) e óbitos 78.503 (28%) no mundo. O Brasil, ocupa o 8º lugar com 145.328 (4%) dos casos confirmados de COVID-19, a sua letalidade está em 6,8% e a mortalidade é de 46,6 por 1.000.000 de habitantes. Em 2020, registrou-se 107.895 hospitalizações por Síndrome Respiratória Aguda Grave no Brasil, desse total, 27.086 (25%) eram casos confirmados de COVID-19 e 7.514 (28%) evoluíram para óbito, sendo as pessoas com 60 anos ou mais 5.697 (69%) dos casos e as cardiopatias e o diabetes os grupos de risco que destacaram-se consideravelmente nos óbitos dos idosos. Conclusão: a doença ainda não está sob controle, o distanciamento social e o uso de máscaras são a melhor forma de evitar a progressão de casos e mortes por COVID-19.Research, Society and Development2020-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/465310.33448/rsd-v9i7.4653Research, Society and Development; Vol. 9 No. 7; e630974653Research, Society and Development; Vol. 9 Núm. 7; e630974653Research, Society and Development; v. 9 n. 7; e6309746532525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4653/4022Copyright (c) 2020 Gabriel Mauriz de Moura Rocha, Aldenora Maria Ximenes Rodrigues, Bruno Nascimento Sales, Grasyele Oliveira Sousa, Guilherme Antônio Lopes de Oliveirainfo:eu-repo/semantics/openAccessSousa, Grasyele OliveiraSales, Bruno NascimentoRodrigues, Aldenora Maria XimenesRocha, Gabriel Mauriz de MouraOliveira, Guilherme Antônio Lopes de2020-08-20T18:05:03Zoai:ojs.pkp.sfu.ca:article/4653Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:26.086822Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Epidemiological evolution of COVID-19 in Brazil and worldwide
Evolución epidemiológica de COVID-19 en Brasil y en todo el mundo
Evolução epidemiológica da COVID-19 no Brasil e no mundo
title Epidemiological evolution of COVID-19 in Brazil and worldwide
spellingShingle Epidemiological evolution of COVID-19 in Brazil and worldwide
Sousa, Grasyele Oliveira
Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
title_short Epidemiological evolution of COVID-19 in Brazil and worldwide
title_full Epidemiological evolution of COVID-19 in Brazil and worldwide
title_fullStr Epidemiological evolution of COVID-19 in Brazil and worldwide
title_full_unstemmed Epidemiological evolution of COVID-19 in Brazil and worldwide
title_sort Epidemiological evolution of COVID-19 in Brazil and worldwide
author Sousa, Grasyele Oliveira
author_facet Sousa, Grasyele Oliveira
Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
author_role author
author2 Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Sousa, Grasyele Oliveira
Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
dc.subject.por.fl_str_mv Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
topic Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
description Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.
publishDate 2020
dc.date.none.fl_str_mv 2020-05-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4653
10.33448/rsd-v9i7.4653
url https://rsdjournal.org/index.php/rsd/article/view/4653
identifier_str_mv 10.33448/rsd-v9i7.4653
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4653/4022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 7; e630974653
Research, Society and Development; Vol. 9 Núm. 7; e630974653
Research, Society and Development; v. 9 n. 7; e630974653
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052650613637120